Shareholding for the Period Ended March 31, 2016
Orchid Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2016. For more details, kindly Click here21-04-2016
21-04-2016
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
K Raghavendra Rao has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201118-04-2016
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended March 31, 2016
Orchid Pharma Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.16-04-2016
Orchid Pharma shares gain 13% on successful inspection report from USFDA for TN facility
Orchid Pharma shares advanced as much as 13 per cent after it informed bourses that the company has received the Establishment Inspection Report (EIR) from US Food and Drug Administration11-04-2016
Updates
Orchid Pharma Ltd has informed BSE that Orchid received the Establishment inspection report (EIR) from USFDA based on the successful inspection closure for the API manufacturing facility located at Alathur, Kancheepuram District, India. The facility was inspected by USFDA in the month of August 2015.11-04-2016
Orchid gets final nod from USFDA for Parkinson's drug
Orchid Pharma stock was trading up 12.18% at Rs 41.90 during the afternoon trade on BSE17-03-2016
Orchid receives final USFDA nod for Rasagiline generic formulation
Orchid Pharma Ltd has informed BSE regarding a Press Release dated March 17, 2016 titled "Orchid receives final USFDA nod for Rasagiline generic formulation".17-03-2016
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
K Raghavendra Rao has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE14-03-2016
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
K Raghavendra Rao has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE23-02-2016
Results Press Release for December 31, 2015
Orchid Pharma Ltd has informed BSE about : 1. Result Press Release for the period ended December 31, 201511-02-2016